Evidence map›Paper›PMID 41098675›Full record

ArticleStatistical science : a review journal of the Institute of Mathematical Statistics2020

Statistical Inference for the Evolutionary History of Cancer Genomes.

Khanh N Dinh, Roman Jaksik, Marek Kimmel, Amaury Lambert, Simon Tavaré

Abstract read
In one paragraph

Article in Statistical science : a review journal of the Institute of Mathematical Statistics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Statistical Inference for the Evolutionary History of Cancer Genomes.Statistical science : a review journal of the Institute of Mathematical Statistics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Khanh N DinhDepartment of Statistics, Columbia University, New York, New York 10027, USA.
Roman JaksikSilesian University of Technology, Gliwice, Poland.
Marek KimmelStatistics and Bioengineering, Rice University with an adjunct appointment at the Silesian University of Technology, Gliwice, Poland.
Amaury LambertLab of Probability, Statistics & Modeling, Sorbonne Université, Paris, France. He also runs a research group at the Center for Interdisciplinary Research in Biology, Collège de France, Paris, France.
Simon TavaréHerbert and Florence Irving Director of the Irving Institute for Cancer Dynamics, and a professor in Statistics and Biological Sciences at Columbia University, New York, New York 10027, USA, and a Senior Associate Core Member, New York Genome Center, New York, New York 10013, USA.

Funding

Multiscale Modeling of Myelodysplastic SyndromesR01HL128173 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI COREY, SETH JOEL, KIMMEL, MAREK · 2015 to 2019
$3.8M
NHLBI NIH HHS R01 HL128173
6 · The paper itself

Abstract

Recent years have seen considerable work on inference about cancer evolution from mutations identified in cancer samples. Much of the modeling work has been based on classical models of population genetics, generalized to accommodate time-varying cell population size. Reverse-time, genealogical views of such models, commonly known as coalescents, have been used to infer aspects of the past of growing populations. Another approach is to use branching processes, the simplest scenario being the classical linear birth-death process. Inference from evolutionary models of DNA often exploits summary statistics of the sequence data, a common one being the so-called Site Frequency Spectrum (SFS). In a bulk tumor sequencing experiment, we can estimate for each site at which a novel somatic point mutation has arisen, the proportion of cells that carry that mutation. These numbers are then grouped into collections of sites which have similar mutant fractions. We examine how the SFS based on birth-death processes differs from those based on the coalescent model. This may stem from the different sampling mechanisms in the two approaches. However, we also show that despite this, they are quantitatively comparable for the range of parameters typical for tumor cell populations. We also present a model of tumor evolution with selective sweeps, and demonstrate how it may help in understanding the history of a tumor as well as the influence of data pre-processing. We illustrate the theory with applications to several examples from The Cancer Genome Atlas tumors.

Indexed as

birth-death processesbulk sequencingCancer evolutionclonal selectioncoalescentsploidysite frequency spectrumtumor heterogeneity

Identifiers

PMID41098675
PMCPMC12519734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.